CD4 as A Target for SARS-CoV-2 Antibody Development from Creative Biolabs

Supplier Page

Supplier Page from
Creative Biolabs for
CD4 as A Target for SARS-CoV-2 Antibody Development

Description

Creative Biolabs offers neutralizing antibody development services against CD4 (Ibalizumab) for SARS-CoV-2 infection.